ResMed Inc (RMD)
178.81
+1.20
(+0.68%)
USD |
NYSE |
Apr 19, 16:00
178.81
0.00 (0.00%)
After-Hours: 20:00
ResMed Cash from Operations (TTM): 1.079B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.079B |
| September 30, 2023 | 934.92M |
| June 30, 2023 | 693.30M |
| March 31, 2023 | 535.35M |
| December 31, 2022 | 370.22M |
| September 30, 2022 | 461.47M |
| June 30, 2022 | 351.15M |
| March 31, 2022 | 498.19M |
| December 31, 2021 | 577.02M |
| September 30, 2021 | 527.06M |
| June 30, 2021 | 736.72M |
| March 31, 2021 | 840.46M |
| December 31, 2020 | 883.88M |
| September 30, 2020 | 783.89M |
| June 30, 2020 | 802.26M |
| March 31, 2020 | 613.81M |
| December 31, 2019 | 513.76M |
| September 30, 2019 | 573.30M |
| June 30, 2019 | 459.05M |
| March 31, 2019 | 446.65M |
| December 31, 2018 | 456.08M |
| September 30, 2018 | 459.16M |
| June 30, 2018 | 505.03M |
| March 31, 2018 | 515.92M |
| December 31, 2017 | 434.44M |
| Date | Value |
|---|---|
| September 30, 2017 | 421.79M |
| June 30, 2017 | 414.05M |
| March 31, 2017 | 416.70M |
| December 31, 2016 | 473.85M |
| September 30, 2016 | 509.57M |
| June 30, 2016 | 547.93M |
| March 31, 2016 | 504.67M |
| December 31, 2015 | 470.86M |
| September 30, 2015 | 421.25M |
| June 30, 2015 | 383.18M |
| March 31, 2015 | 399.06M |
| December 31, 2014 | 409.22M |
| September 30, 2014 | 387.38M |
| June 30, 2014 | 391.27M |
| March 31, 2014 | 399.61M |
| December 31, 2013 | 405.51M |
| September 30, 2013 | 414.99M |
| June 30, 2013 | 402.82M |
| March 31, 2013 | 375.88M |
| December 31, 2012 | 354.90M |
| September 30, 2012 | 371.89M |
| June 30, 2012 | 383.16M |
| March 31, 2012 | 360.51M |
| December 31, 2011 | 355.89M |
| September 30, 2011 | 313.57M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
351.15M
Minimum
Jun 2022
1.079B
Maximum
Dec 2023
643.94M
Average
577.02M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
| Stryker Corp | 3.711B |
| Boston Scientific Corp | 2.503B |
| Integer Holdings Corp | 180.21M |
| Haemonetics Corp | 197.28M |
| Insulet Corp | 145.70M |